StockData
ImageneBio, Inc. logo

ImageneBio, Inc. (IMA) stock

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.90+0.70 (+21.87%)

Close on Nov 17, 2026Market cap $44.27MP/E –Yield –

ImageneBio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

ImageneBio's price to sales ratio was 36.7× on Apr 30, 2026, against 83.5× a year earlier. Over the last 4 years it ranged from 30.4× to 498.4×, with a median of 96.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 202636.7×−96.7
2025Dec 31, 2025133.4×+49.9
2024Apr 30, 202483.5×+8.7
2023Dec 29, 202374.7×+36.6
2022Dec 30, 202238.1×−460.3
2021Dec 31, 2021498.4×–

More ImageneBio figures

See a number that looks wrong?